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Abstract
Background: Intravaginal practices are commonly used by women to manage their vaginal health and sexual life. These
practices could, however, affect intravaginal mucosal integrity. The objectives of this study were to examine evidence for
associations between: intravaginal practices and acquisition of HIV infection; intravaginal practices and vaginal infections;
and vaginal infections and HIV acquisition.
Methodology/Principal Findings: We conducted a systematic review of prospective longitudinal studies, searching 15
electronic databases of journals and abstracts from two international conferences to 31st January 2008. Relevant articles
were selected and data extracted in duplicate. Results were examined visually in forest plots and combined using random
effects meta-analysis where appropriate. Of 2120 unique references we included 22 publications from 15 different studies in
sub-Saharan Africa and the USA. Seven publications from five studies examined a range of intravaginal practices and HIV
infection. No specific vaginal practices showed a protective effect against HIV or vaginal infections. Insertion of products for
sex was associated with HIV in unadjusted analyses; only one study gave an adjusted estimate, which showed no
association (hazard ratio 1.09, 95% confidence interval, CI 0.71, 1.67). HIV incidence was higher in women reporting
intravaginal cleansing but confidence intervals were wide and heterogeneity high (adjusted hazard ratio 1.88, 95%CI 0.53,
6.69, I2 83.2%). HIV incidence was higher in women with bacterial vaginosis (adjusted effect 1.57, 95%CI 1.26, 1.94, I2 19.0%)
and Trichomonas vaginalis (adjusted effect 1.64, 95%CI 1.28, 2.09, I2 0.0%).
Conclusions/Significance: A pathway linking intravaginal cleaning practices with vaginal infections that increase
susceptibility to HIV infection is plausible but conclusive evidence is lacking. Intravaginal practices do not appear to
protect women from vaginal infections or HIV and some might be harmful.
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Introduction
Intravaginal practices comprise a variety of behaviors that
women use to positively manage their health and sexual life [1].
Women often use these practices to achieve a desired intravaginal
state, which they believe will keep them clean and free from disease,
and sexually desirable [2]. Vaginal stratified squamous epithelium is
an important barrier to infection but physical, chemical, or
biological factors associated with intravaginal practices could allow
HIV to infect intraepithelial Langerhans cells or be taken up by
migratory dendritic cells and disseminated to regional lymph nodes
[3]. For example, insertion or application of substances like herbs,
pulverized rock, or commercial products to prepare the vagina for
sexual intercourse can cause physical or chemical abrasions [4] that
could be exacerbated during intercourse [3]. These kinds of
practices have previously been referred to as ‘dry sex’ [5,6]. Wiping
out the vagina with cloth, cotton wool or paper during sex [7] or
after intravaginal cleansing might have similar effects. Soaps,
detergents and antiseptics used to wash inside the vagina can cause
chemical damage [8] and increase vaginal pH, encouraging the
growth of organisms associated with bacterial vaginosis [9], a
condition shown to increase women’s risk of HIV infection
acquisition in many prospective studies [10]. Cloths used commonly
in some countries to clean the vagina repeatedly might also act as
fomites, harboring Trichomonas vaginalis, which can increase the risk
of HIV acquisition [11,12].
Biological and epidemiological data have been integrated to
hypothesize a pathway linking intravaginal practices with acquisition
of HIV infection, which might be mediated by changes in vaginal
flora or vaginal infections that disrupt mucosal integrity (Figure 1)
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[1,13,14]. Results from individual epidemiological studies have been
inconclusive [14–16]. Differences in definitions and classification of
vaginal practices, measures of intensity of exposure, study design,
study population, and methods of statistical analysis might explain
these inconsistent results [17]. In addition, some intravaginal
practices are uncommon and HIV infection is a relatively rare
outcome so potentially important associations could be missed. We
carried out a systematic review to synthesize epidemiological
evidence about the steps along the potential causal pathway
(Figure 1). The specific objectives were to examine associations
between: 1) intravaginal practices and HIV acquisition; 2)
intravaginal practices and vaginal infections; and 3) vaginal
infections and HIV acquisition in prospective studies in women.
Methods
Ethical approval was not required for this review because only
published data were included.
Literature Searches
The authors searched electronic databases from the earliest date
up to 31st January 2008. The full search strategy is available on
request. In brief, we searched Excerpta Medica Database
(EMBASE); Medical Literature Analysis and Retrieval System
Online (MEDLINE); Cumulative Index to Nursing and Allied
Health Literature (CINAHL); the Cochrane Library; and
Educational Resources Information Centre (ERIC) databases
using explosion searches for subject headings or thesaurus terms
for disease outcomes; HIV, bacterial vaginosis, trichomoniasis,
candidiasis. We combined these with free text terms and wildcard
characters related to intravaginal practices, including: vagina;
vulva; intravaginal; dry sex; cleansing; cleaning; washing; cutting;
douching; insertion; practice; lubrication; microbicide and genital
lesions. We used the same combinations of free text keywords to
search ten other electronic databases including Global Health
Library (GHL); Population Information Online (Popline) and
WHO regional indexes. We hand-searched conference abstracts
from the International AIDS Society Conferences, the Conference
on Retroviruses and Opportunistic Infections, the International
Society for STD Research, and Microbicides conferences since
1990. Reference lists of included papers, systematic reviews, letters
and commentaries were examined, and experts were contacted to
identify additional papers. There were no language restrictions.
Selection of Studies
Eligible studies were prospective longitudinal studies or
randomized controlled trials of HIV seronegative women, which
reported on intravaginal practices and documented incident HIV
seroconversions or episodes of bacterial vaginosis, trichomoniasis
or vaginal candidiasis. Case-control studies were included if they
were nested within longitudinal studies. Cross-sectional studies,
editorials, commentaries, letters without original data and case
reports were not included. Articles in languages other than English
were translated by the authors.
Definitions of Intravaginal Practices
We based our definitions on practices identified during a
qualitative research study in four countries in sub-Saharan Africa
and South East Asia [2]. We considered four eligible categories of
intravaginal practice: intravaginal cleansing with liquids (including
douching); insertion of dry substances into the vagina; ingestion of
substances intended to affect the vagina; and self-administered
anatomical modifications, such as cutting at the introitus, with
insertion into the cut of traditional substances that are washed away
later. We attempted to further define each category of intravaginal
practice according to the means of application or delivery and
specific products used. External practices involving washing,
steaming (or ‘‘fogging’’) and application of substances onto the labia
or vulva were not eligible. We excluded female genital mutilation or
elective surgery to alter vaginal anatomy because these are not done
by the woman herself. We also excluded use of sex toys, use of
female and male condoms and other barrier contraceptives such as
the diaphragm or sponge, other devices for delivering of
medications, and tampons or other commercial products for the
absorption of menstrual blood. Previous qualitative research in
southern Africa has found that local African languages have different
words for intravaginal and external washing so differences between
these practices are understood [2]. We therefore assumed that
studies describing vaginal washing, cleansing or insertion meant
practices that affected the vaginal mucosa beyond the introitus and
not just the vulva.
Definition of Outcomes
The primary outcome was incident HIV-1 infection, as defined
by authors of each study. We defined intermediate vaginal
conditions as investigator-defined criteria for: bacterial vaginosis
(Nugent score of 7 to 10 [18] or 3 or more Amsel criteria [19]);
disturbed vaginal flora (Nugent score 4 to 6); vaginal yeast
infections including candidiasis; and Trichomonas vaginalis. Inter-
mediate outcomes could also be examined as potential exposures
with HIV infection as the outcome.
Assessment of Validity
We assessed the methodological quality of all included studies
using the United Kingdom National Institute for Health and
Clinical Excellence (NICE) criteria to assess the quality of
reporting in key methodological domains [20]. We included all
studies in analyses, irrespective of quality but noted methodolog-
Figure 1. Simplified hypothesized pathways linking intravaginal practices and HIV. Intravaginal practices are hypothesized to cause
physical or chemical damage to vaginal epithelium. In response, changes in vaginal flora associated with bacterial vaginosis occur, or colonization by
other vaginal pathogens occurs. These conditions facilitate HIV transmission. Intravaginal practices might also increase the transmission of HIV
through a direct effect or other pathways. Numbers refer to the objectives of the review. Objective 1 includes the estimation of the association
between intravaginal practices and HIV infection. Objective 2 estimates the association between intravaginal practices and vaginal infections.
Objective 3 estimates the association between disrupted vaginal flora, bacterial vaginosis or other vaginal infections and HIV-1 acquisition.
doi:10.1371/journal.pone.0009119.g001
Intravaginal Practices and HIV
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ical issues that might affect results, such as the lack of an adjusted
effect estimate.
Data Abstraction
We used standardized study selection and data extraction forms.
Two teams of two reviewers each (SCF and NB, AMH and MC)
assessed the papers for eligibility and extracted data independent-
ly. Discrepancies were resolved by discussion or by consultation
with a third reviewer (NL). Data items extracted included study
population, baseline characteristics, participant retention, and
unadjusted and adjusted summary measures with confidence
intervals, and lists of variables included in multivariable models.
We did not contact authors for additional information. Data were
double entered into an Epidata database (Epidata, Odense,
Denmark).
Statistical Analysis
Data were analyzed using Stata, version 10 (StataCorp, College
Station, TX). We examined the point estimates and 95%
confidence intervals (95% CI) of exposure-outcome pairs in each
study according to the study objectives and displayed these in
forest plots. We took the rate ratio as the most appropriate effect
measure. We assumed that hazard ratios and risk ratios
approximated the rate ratio. In nested case control studies, we
assumed that the odds ratio approximated the rate ratio if the
selection of controls was matched on time and if the analysis took
this into account [21]. If the analysis did not take into account
matching on time we reported the odds ratio and did not combine
these with other effect estimates. We report the original effect
measure for single studies and pooled analyses of studies using the
same measure. We report pooled analyses from different study
designs as summary unadjusted or adjusted effects. Associations
reported in more than one publication from the same study were
only included once. We examined heterogeneity using the I2
statistic, which describes the percentage of total variation across
studies that is due to heterogeneity other than chance [22]. An I2
value of 50–75% was interpreted as indicating moderate
heterogeneity and a value of .75% as showing pronounced
between study heterogeneity. If there were more than two reports
of the same exposure-outcome pairing from different studies we
combined results using a random effects model. If there was strong
evidence of statistical heterogeneity we attempted to examine
potential explanations in stratified analyses. Funnel plots were
examined using statistical methods for detecting asymmetry
indicative of small study biases [23].
Results
Our broad search strategies identified 2120 articles (Figure 2);
most (70% of unique titles) could be excluded from the title alone.
Of 144 full text articles, two thirds of those excluded (79/121) were
investigations of microbicides or other ineligible interventions. We
included 22 publications from 15 prospective studies (Table 1)
[7,8,11,14–16,24–39]. One report published after the end of the
search period [14] was included because preliminary results had
been published in a letter identified by our search strategy [39]
and another was in press at the end of the search period [33].
Twenty publications were based on 13 studies in nine sub-Saharan
countries (South Africa, N= 4,121 women with follow-up
[16,29,34], Zimbabwe, N= 3,139 women [8,14,30,38,39], Kenya,
N= 1,335 women [11,15,31–33], Uganda, N= 2,235 women
[14,39], Tanzania, N= 1,442 women [28,36], Zambia, N= 724
women [7,26], Cote d’Ivoire, N= 284 women [24], Malawi,
N= 2,538 women [30,37], Burkina Faso, N= 273 women [35]
and the other two publications were from studies conducted in the
United States (N= 1,348 women) [25,27].
Of the 22 included publications (Table 1), seven investigated the
association between intravaginal practices and HIV acquisition in
five studies (objective 1) [7,14–16,24,34,39]; eight explored
associations between intravaginal practices and prevalent vaginal
infections (objective 2) [14,25,27,33–35,38,39] in six separate
studies; 11 publications in nine studies investigated associations
between bacterial vaginosis and HIV acquisition (objective 3)
[14,16,28–32,34,36,37,39]; nine publications in seven studies
reported on the association between trichomoniasis and HIV-1
(objective 3) [11,16,24,26,28,29,31,34,37]; and six publications in
five different studies reported on the association between vaginal
yeast and HIV (objective 3) [14,26,28,31,37,39]. The only
statistical evidence of small study biases in summary effects was
for unadjusted (Egger test p = 0.003) estimates of the association
between bacterial vaginosis and HIV. The risk of bias, assessed
from the publications, were variable (Table S1). Only one study
did not report any multivariable analyses [7], even though relevant
adjusted analyses for the associations of interest in this review were
often not reported. The reliability of instruments used to record
intravaginal practices was less well documented than laboratory
exposures and outcomes. The numbers of eligible women who
accepted participation were generally poorly reported. Blinding to
reduce bias was rarely reported explicitly.
Types of Intravaginal Practices
Types of intravaginal practices were described in 14 publica-
tions from eight studies (Table 1). The most frequently investigated
practices involved intravaginal cleansing with liquids. Two studies
on vaginal douching from the USA [25,27] described the use of
specific douche applicators and commercial products [27], mainly
for cleanliness or hygiene [25]. In sub-Saharan Africa, a wider
variety of practices was investigated. Intravaginal cleansing with
water or soap and water were investigated most frequently [8,14–
16,31–34,38,39]. We categorized the practice described as
‘‘douching’’ with soap and water in Burkina Faso as intravaginal
washing [35] because no specific douche applicator was
mentioned and the use of specific douching applicators was
reported to be very uncommon elsewhere in Africa [15]. Other
household cleaners and antiseptics [16,33], vinegar or lemon juice
[16] were less commonly included in questionnaires and reported.
Where the method used to apply liquids was asked about, fingers
were used most commonly [8,11,15,16,34,38,40], with cloth used
less often [11,14–16,33,34]. Practices aimed at drying or
tightening the vagina in preparation for, or during sexual
intercourse included: insertion of dry herbs [24], use of a cloth
before or during sex [7], or unspecified products [14,16,32]. We
did not identify any study that specifically investigated the
application or ingestion of substances aimed at affecting the
vagina or anatomical modifications to the vulva and vagina despite
the fact that these practices are also employed to dry and tighten
the vagina, or self treat [2]. Combinations of practices, products
and methods of application, or ‘any vaginal practice’ were
described in some publications [8,14–16,33,34,38].
Intravaginal Practices and HIV Acquisition
Five studies reported on associations between any kind of
intravaginal practice and incident HIV-1 infection in analyses that
included 4,169 women with more than 253 HIV infections
(number not reported in one study) in seven publications (Table 2,
Figure 3 and Table S2) [7,14–16,24,34,39]. All studies were
carried out in sub-Saharan Africa, including two in female sex
worker populations [15,24]. There was some evidence of an
Intravaginal Practices and HIV
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Figure 2. Flow chart of identification and selection of studies for inclusion. Steps followed to identify relevant studies and select those
eligible for inclusion in the review. Publications and studies in the box ‘Studies included’ could address multiple objectives and are included in each
relevant ‘Objective’ below. EMBASE, Excerpta Medica Database; MEDLINE (Ovid), Medical Literature Analysis and Retrieval System Online; CINAHL,
Cumulative Index to Nursing and Allied Health Literature; Cochrane, Cochrane Library (John Wiley); ERIC, Educational Resources Information Centre;
GHL, Global Health Library; Popline, Population Information Online.
doi:10.1371/journal.pone.0009119.g002
Intravaginal Practices and HIV
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Table 1. Characteristics of included studies.
First author,
publication year
[reference no.] Country
Study
design
Population/
setting Numbera
Duration of follow
up (median or
woman years)
Vaginal practices
described by authors
Objective
numberb
Enrolled
Follow
up
Ghys, 2001 [24] Coˆte d’Ivoire RCT Sex worker
STD clinic
542 284 318 woman years Vaginal use of herbs 1, 3
Hawes, 1996 [25] USA Cohort STD clinic
attenders
209 182 16 months (median) Douching 2
Hester, 2003 [26] Zambia Case-
control
Living with HIV
positive partner
Not
reported
90 3 months (planned) Not measured 3
Hira, 1990 [7] Zambia Cohort University hospital,
post-partum
1720 634 12 months (planned) ‘Dry sex’ (cloth used to
remove vaginal secretions
during sex)
1
Hutchinson,
2007 [27]
USA Cohort Women at risk
of PID
1193 1166 36 months (median) Douching 2
Kapiga, 2007 [28] Tanzania Cohort Women working
in bars
845 689 699 woman years Not measured 3
Kleinschmidt,
2007 [29]
S Africa Cohort Family planning
clinics
551 551 491 woman years Not measured 3
Kumwenda,c
2006 [30]
Malawi,
Zimbabwe
Cohort Family planning or
postnatal clinics
2016 2016 2429 woman years Not measured 3
Martin,c 1998 [31] Kenya Cohort Sex worker
STD clinic
953 779 880 woman years Vaginal cleansing: water,
soap/detergent/disinfectant;
vaginal drying
3
Martin,d
1999 [32]
Kenya Cohort Sex worker
STD clinic
953 657 621 woman years 3
McClelland,d
2006 [15]
Kenya Cohort Sex worker
STD clinic
1496 1270 2877 woman years Vaginal cleansing: water,
soap/detergent/disinfectant;
insertion of herbs; use of
finger, cloth, douche bag
1
McClelland,d
2007 [11]
Kenya Cohort Sex worker
STD clinic
1579 1335 3422 woman years Vaginal cleansing: water, soap/
antiseptic; use of finger, cloth;
lubricant
3
McClelland,d
2008 [33]
Kenya RCT
placebo
Sex worker
STD clinic
154 151 153 woman years 2
Myer,e 2005 [34] S Africa Case-
control
Cervical cancer
screening trial
5110 410 36 months Wiping inside with water, cloth
and/or fingers; sometimes soap
or other cleaning agents
1, 2, 3
Myer,e 2006 [16] S Africa RCT Cervical cancer
screening trial
4139 3570 4641 woman years Cloth or fingers, alone or with
water; soaps; disinfectants;
vinegar; salt water; industrial
detergents
1, 3
Nagot, 2007 [35] Burkina
Faso
Cohort Sex workers 279 273 8.5 months (mean) ‘Vaginal douching’ using
soap and water, or other
unspecified products
2
Riedner, 2006 [36] Tanzania Cohort Women working
in bars
600 753 Up to 27 months Not measured 3
Taha, 1998 [37] Malawi Cohort Antenatal clinics 1196 1196
antenatal
3.4 months (median
antenatal)
Not measured 3
1169
postnatal
2.5 years (median
postnatal)
van de Wijgert,f
2000a [38]
Zimbabwe Cohort Family planning,
primary care,
postnatal clinics
169 169 6 months (median) Any vaginal practice (finger
cleansing with products
other than water, wiping
inside vagina .12 times
past month, inserting
traditional substances
.4 times
past month
2
van de Wijgert,f
2000b [8]
Zimbabwe Cohort Family planning,
primary care,
postnatal clinics
169 169 6 months (median) 2
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increased risk of HIV acquisition in unadjusted analyses of these
five studies (summary effect 2.65, 95% CI 0.95–7.36, I2 92.0%).
Only two studies provided adjusted effect estimates [14,16]. Three
studies reported hazard ratios for the use of intravaginal cleansing
with any product [14–16]. These suggested harm in unadjusted
analyses of all three studies (1.39, 95% CI 0.76–2.54, I2 76.6%)
and adjusted analyses including only two studies (adjusted effect
estimate 1.88, 95% CI 0.53, 6.69, I2 83.2%) [15,16] but
confidence intervals were wide and heterogeneity high. In two
studies reporting on insertion of herbs or unspecified substances to
dry and tighten the vagina before sexual intercourse the summary
unadjusted effect was 1.47 (95% CI 1.03–2.10, I2 0%) [14,24]. An
adjusted measure was only reported by van de Wijgert et al. [14].
The most marked effect of any practice was reported by Hira, with
an increased risk in post-natal women who reported using cloth to
wipe out the vagina during intercourse (risk ratio 27.68, 95% CI
10.66–71.92), but loss to follow up from the original cohort was
high and there was no multivariable analysis [7]. Myer et al. found
no adverse effect in women who reported using cloth inside the
vagina (unadjusted hazard ratio 0.96, 95% CI 0.49–1.87) but an
increased risk of HIV in women who used fingers to clean the
vagina (unadjusted hazard ratio 3.66, 95% CI 1.82–7.37) [16].
Intravaginal Practices and Vaginal Infections
Associations between intravaginal practices and incident
bacterial vaginosis or disturbance of intravaginal flora were
reported in six studies involving 6,503 women in analyses
[14,25,27,33–35] (Table 2, Figure 3 and Table S3). The summary
measure of effect in unadjusted analyses of three studies suggested
an association between intravaginal douching or washing and
bacterial vaginosis in women with normal flora at baseline (1.20,
95% CI 1.03–1.40, I2 0%) [33–35]. This was attenuated in an
adjusted summary effect that included different studies (1.12, 95%
CI 0.82–1.54, I2 49.2%) [25,27,33,35]. In Zimbabwe and Uganda,
First author,
publication year
[reference no.] Country
Study
design
Population/
setting Numbera
Duration of follow
up (median or
woman years)
Vaginal practices
described by authors
Objective
numberb
Enrolled
Follow
up
van de Wijgert,g
2006 [39]
Uganda,
Zimbabwe
Cohort Family planning,
primary care clinics
4531 4531 22 months (mean) Anything to dry or tighten
vagina for sex, anything to
clean inside vagina. If yes,
prompt about products
1
van de Wijgert,g
2008 [14]
Uganda,
Zimbabwe
Cohort Family planning,
primary care clinics
4531 4531 22 months (mean) 1, 2, 3
Legend:
PID, pelvic inflammatory disease; RCT, randomized controlled trial; STD, sexually transmitted diseases.
aNumber of HIV negative women enrolled; number of women in analyses with at least one follow up visit, or number in case-control study.
bObjective 1, associations between intravaginal practices and incident HIV; objective 2, associations between intravaginal practices and vaginal infections; objective 3,
associations between vaginal infections and incident HIV infection.
cIncludes 1342 women from Malawi, 674 from Zimbabwe.
dPublications from the same study of an open cohort of sex workers in Mombasa Kenya.
ePublications from the same RCT of a cervical screening intervention in Kayelitsha, South Africa.
fPublications from the same study of the effects of intravaginal practices on vaginal and cervical mucosa.
gPublications from the same study of Hormonal Contraception and Risk of HIV Acquisition in Uganda (2235 women) and Zimbabwe (2296 women).
doi:10.1371/journal.pone.0009119.t001
Table 1. Cont.
Table 2. Summary effect estimates for studies reporting associations between intravaginal practices and HIV-1 (objective 1), and
intravaginal practices and vaginal infections (objective 2).
Intravaginal practice Outcome Unadjusted effect estimate Adjusted effect estimate
(Study ref.) Summary (95% CI) I2 (Study ref.) Summary (95% CI) I2
Any vaginal practicea HIV [7,14–16,24] 2.65 (0.95, 7.36) 92.0% [14,16] 0.87 (0.67, 1.13) 0.0%
Intravaginal cleansingb HIV [14–16] 1.39 (0.76, 2.54) 76.6% [15,16] 1.88 (0.53, 6.69) 83.2%
Insertion of substancesc HIV [14,24] 1.47 (1.03, 2.10) 0.0% [14] 1.09 (0.71, 1.67) ..
Any vaginal practiced BV [14,34,35] 1.20 (1.09, 1.34) 0.0% [25,27,35] 1.31 (0.87, 1.97) 38.8%
Intravaginal cleansing or douchinge BV [33–35] 1.20 (1.03, 1.40) 0.0% [25,27,33–35] 1.12 (0.82, 1.54) 49.2%
Legend:
aIncludes: ‘anything to dry or tighten your vagina for sex’ or ‘anything to clean the inside of your vagina’ [14]; intravaginal washing with water, soap or other substances
including detergents and antiseptics [15]; ‘any intravaginal practice reported’ [16]; insertion of herbs [24].
bIncludes: ‘anything to clean the inside of your vagina’ [14]; intravaginal washing with soap [15]; ‘any intravaginal practice reported’ [16].
cIncludes: ‘anything to dry or tighten your vagina for sex’ [14]; insertion of herbs [24].
dIncludes: ‘anything to dry or tighten your vagina for sex’ or ‘anything to clean the inside of your vagina’ [14]; ‘douching for cleanliness’ [25]; ‘douching’ [27]; ‘wiping
inside the vagina with water, cloth and/or fingers and sometimes with soap or other cleaning agents as part of regular hygiene [34]; ‘vaginal douching using only soap
and/or water’ [35].
doi:10.1371/journal.pone.0009119.t002
Intravaginal Practices and HIV
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Figure 3. Forest plot of all reported and quantified associations between intravaginal practices and any infection. Forest plot
showing unadjusted and/or adjusted effect estimates reported in included studies, according to the infection studied as the outcome. Individual
studies can be included more than once if multiple outcomes are reported. If both unadjusted and adjusted effects were reported for the same
combination of practice, product and applicator, these are presented with the unadjusted effect estimate above the adjusted effect estimate. No
pooled estimates are shown in this plot. Minor differences between effect estimates in the table and those in published papers are possible.
doi:10.1371/journal.pone.0009119.g003
Intravaginal Practices and HIV
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insertion of substances to dry or tighten the vagina before sexual
intercourse was associated with incident bacterial vaginosis in
univariable but not multivariable analyses [14]. Trichomoniasis
and candidiasis were studied as outcomes following intravaginal
practices in only two studies [14,25]. Hawes et al. found no
statistical evidence for an association between douching and
trichomonas or candidiasis [25], whilst insertion of substances for
drying or tightening the vagina [14] was associated with vaginal
candida in univariable analyses (Figure 3).
Vaginal Infections and Incident HIV Infection
There was strong and consistent evidence of associations
between bacterial vaginosis and HIV and between trichomoniasis
and HIV in both unadjusted and adjusted analyses (Figure 4).
Evidence of an association between vaginal yeast infections and
HIV infection was based on fewer studies and showed heteroge-
neous results in unadjusted (summary effect 1.69, 95% CI 0.67–
4.31, I2 81%) and adjusted analyses (summary effect 2.19, 0.97–
4.94, I2 87%).
Discussion
This systematic review and meta-analysis of 22 publications
from 15 studies in sub-Saharan Africa and the USA found no
evidence that intravaginal practices reduce the incidence of
vaginal infections or HIV. There was inconclusive statistical
evidence about the effect of intravaginal practices on women’s risk
of acquiring HIV infection; the direction of summary measures of
associations suggested harm, but confidence intervals were wide
and there were high levels of heterogeneity. There was evidence of
an association between intravaginal washing and douching
practices and bacterial vaginosis in unadjusted but not adjusted
analyses. There was strong statistical evidence that bacterial
vaginosis and trichomoniasis increase women’s risk of acquiring
HIV infection.
The main strength of this study was the comprehensive search
for studies examining all stages of a potential pathway linking
intravaginal practices and HIV infection. Our systematic searches
of multiple databases without language restrictions are unlikely to
have missed important prospective studies of intravaginal practices
and HIV infection. The specific keywords used to identify
individual vaginal infections might, however, have failed to
identify studies that were indexed only under the general term
‘sexually transmitted diseases’. We also attempted to distinguish
the effects of different intravaginal practices using categories based
on empirical research that describe practices according to the type
of practice, method of application and product [2]. Across all
included studies, however, measurement of vaginal practices,
grouping of practice types and the period of recall varied, limiting
direct comparisons between studies and identification of specific
potential harms. We were only able to estimate the effects for
broad categories of practice such as intravaginal cleansing with
any product, or use of any product for drying and tightening the
vagina for sex. Between study heterogeneity in study populations
and the practices included therefore limit interpretation if
combinations of practices or products with different effects dilute
the associations. There was some evidence for small trials bias in
one analysis only; the unadjusted association between bacterial
vaginosis and HIV. However, this association persisted in the
adjusted analysis for which there was no statistical evidence of such
biases.
One previous review examined associations between intravag-
inal practices, vaginal infections and HIV [13]. Myer and
colleagues identified and included both cross-sectional and
prospective studies published up to 2004 and found strong
evidence of an association between any intravaginal practices
and prevalent HIV infection and when combining unadjusted and
adjusted estimates. The association between intravaginal practices
and HIV infection in three studies suggested a harmful effect but
confidence intervals were wide (summary estimate 3.85, 95% CI
0.52, 28.27). In this review that includes several more recently
published studies we only included prospective studies enrolling
HIV seronegative women so that the temporal sequence of events
between intravaginal practices and HIV infection was clear. We
also studied a wider range of potential intermediate infections,
including vaginal yeast and trichomoniasis. Few other studies have
examined all links in this putative pathway. In a large study
conducted in Uganda and Zimbabwe, van de Wijgert et al.
concluded that the use of all intravaginal practices combined did
not increase the risk of vaginal infections or HIV [14]. In our
review, we also found some evidence in unadjusted analyses that
any vaginal practice, products inserted to dry or tighten the vagina
for sex, and products used for intravaginal cleansing increased
women’s risk of acquiring HIV infection. Adjusted summary
measures were difficult to interpret because they included fewer
studies, some of which were different from those in the unadjusted
analyses.
Our review showed no evidence that the intravaginal practices
investigated protect against the development of bacterial vaginosis,
or acquisition of other vaginal infections or HIV, even though
previous studies have found that women report that improving
genital hygiene and treating symptoms are common motivations
for these practices [2,17,41]. Women might be using intravaginal
practices to assert control over their sexuality and health without
realizing that the products and methods of application might not
be beneficial. As intravaginal washing practices are common in
sub-Saharan Africa, even small increases in risk for HIV
acquisition could mean a substantial proportion of HIV infections
are attributable to these practices. Grimley et al. showed that a
counseling intervention reduced douching in young women in the
USA [42]. Further trials that attempt to modify intravaginal
practices that are evaluated with biological outcomes would show
whether the incidence of vaginal infections and HIV can also be
reduced.
This study showed strong and consistent evidence that
trichomoniasis increases women’s risk of acquiring HIV [43].
The strength of the association is similar to that for the association
between bacterial vaginosis and incident HIV, which is now well
documented [10] and confirmed in our analyses. Trichomonas
can cause intense vaginal mucosal disruption but subclinical
inflammation in asymptomatic infections might also be sufficient
to increase HIV transmission. Trichomonas is sexually transmitted
but re-infection is common despite partner notification [44].
Another potential route of re-infection might be from cloths,
reported as being used to wipe the vagina for washing [11] or
during sex [7], if trichomonads remain viable on damp cloths. The
association between vaginal practices and trichomonas merits
further study since we found only one small study from the USA,
which found no association [25]. Modification to such practices
might be possible and McClelland et al. found modest evidence
that periodic presumptive treatment reduced the incidence of
trichomonas [40].
The findings of this study have implications for HIV prevention
research, particularly in the field of vaginal microbicide develop-
ment. A sub-group analysis of one trial found some evidence of
benefit of 0.5% PRO 2000/5 gel [45]. Several other phase 3 trials,
however, found that microbicides with favorable in vitro activity
and safety profiles did not prevent, and might have increased, the
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Figure 4. Meta-analyses of studies reporting associations between vaginal infections and HIV, unadjusted and adjusted effect
estimates. Panel A: Bacterial vaginosis is associated with incident HIV infection. Eight studies contribute to the pooled adjusted effect estimate with
little between study heterogeneity. Panel B: Trichomonas vaginalis infection is associated with incident HIV infection. Five studies contribute to the
pooled adjusted effect estimate with no between study heterogeneity. Panel C: Candida or other yeast infections are not consistently associated with
incident HIV infection. Two studies, with differing results contribute to the pooled adjusted effect estimate. Minor differences between effect
estimates in the table and those in published papers are possible.
doi:10.1371/journal.pone.0009119.g004
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risk of HIV infection [46,47]. Intravaginal practices could interfere
with the intended effects of chemical microbicides by washing
them out, diluting them, or interacting chemically to reduce the
expected efficacy. Cervicography has been used to show how
detergents damage and disrupt intravaginal mucosa [48].
Alternatively, previously unidentified mechanisms, such as disrup-
tion of tight junctions in the epithelial barrier, could increase the
risk of HIV transmission [49]. Toxicological studies could help to
find out whether or not soaps and other products that are used
intravaginally inactivate microbicides. Qualitative research would
help us to understand whether or not the timing of or motivations
for intravaginal practices might be interfering with microbicide
delivery. Further individual studies of the association between
intravaginal practices and HIV infection will require very large
numbers of participants and prolonged repeated follow up visits,
however, so that the effects of individual practices, applicators and
products can be examined appropriately. An alternative would be
to pool data from existing studies, create common variables across
studies and conduct individual person data meta-analysis. In
summary, the current evidence shows that intravaginal practices
do not appear to protect women from vaginal infections or HIV
and some might be harmful.
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Table S1 Assessment of reporting of features related to the risk
of bias. *** criterion well-covered; ** criterion adequately
addressed; * criterion poorly addressed; - criterion not addressed
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from reference 20.
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DOC)
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